Dermatomyositis and polymyositis may affect children and adults and are now widely recognized as major causes of disability which, thanks to the introduction of immunosuppressive drugs, is often treatable, at least to some extent. Few data exist regarding polymyositis in elderly patients. We describe a case of refractory life-threatening polymyositis in an elderly patient, successfully treated with intravenous cyclophosphamide
PINTO A, TUTTOLOMONDO A, DI RAIMONDO D, DI GATI M, DI SCIACCA R, FERNANDEZ P, et al. (2006). Successful salvage therapy of intravenous cyclophosphamide for refractory polymyositis in an elderly patient: a case report. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 19 (4), 924-934.
Successful salvage therapy of intravenous cyclophosphamide for refractory polymyositis in an elderly patient: a case report.
PINTO, AntonioPrimo
;TUTTOLOMONDO, Antonino;DI RAIMONDO, Domenico;DI GATI, Maria;DI SCIACCA, Riccardo;FERNANDEZ, Paola;LICATA, GiuseppeUltimo
2006-01-01
Abstract
Dermatomyositis and polymyositis may affect children and adults and are now widely recognized as major causes of disability which, thanks to the introduction of immunosuppressive drugs, is often treatable, at least to some extent. Few data exist regarding polymyositis in elderly patients. We describe a case of refractory life-threatening polymyositis in an elderly patient, successfully treated with intravenous cyclophosphamide
| File | Dimensione | Formato | |
|---|---|---|---|
|
Successful salvage therapy of intravenous cyclophosphamide for refractory polymyositis in an elderly patient a case report..pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
3.16 MB
Formato
Adobe PDF
|
3.16 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
